Conatus Pharmaceuticals Inc (NASDAQ:CNAT)

5.36
Delayed Data
As of May 22
 +0.04 / +0.75%
Today’s Change
5.22
Today|||52-Week Range
11.74
-23.43%
Year-to-Date
No recent news for Conatus Pharmaceuticals Inc.

Today’s Trading

Previous close5.32
Today’s open5.32
Day’s range5.25 - 5.45
Volume195,633
Average volume (3 months)688,561
Market cap$105.8M
Dividend yield--
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)-128.57%
Earnings growth (this year)-12.20%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.51

Competitors

 Today’s
change
Today’s
% change
AXNAoxing Pharmaceutica...-0.07-4.43%
CYNADCynapsus Therapeutic...-0.18-1.13%
TNXPTonix Pharmaceutical...+0.19+2.95%
ATNMActinium Pharmaceuti...-0.14-4.62%
Data as of 4:03pm ET, 05/22/2015

Financials

Next reporting dateAugust 12, 2015
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$0.00
Annual profit (last year)-$22.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Steven J. Mento
Chief Financial Officer, Secretary &
SVP-Finance
Charles J. Cashion
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers